Rheumatoid Arthritis Clinical Trials in Chicago

Showing 1-20 of 2,983 trials

Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

NCT03417544

This research study is studying a drug called atezolizumab as a possible treatment HER2-positive metastatic breast cancer (MBC) that has spread to the brain. The names of the study drugs involved in this study are: * Atezolizumab * Pertuzumab * Trastuzumab

HER2-positive Metastatic Breast CancerCentral Nervous System Metastases

Nancy Lin, MD19 participantsStarted May 2018

Chicago, Illinois, United States • Boston, Massachusetts, United States

Not Yet RecruitingPhase 22.2 miles

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

NCT07549503

This is a prospective multi-center, longitudinal study to determine efficacy of 50 percent Immunosuppression (IS) reduction. One hundred fully eligible participants will reduce IS by 50 percent in two steps. Liver tests will be checked every 0.5 months through month 4, once a month through month 12, and every other month through month 18. Liver transplant (LTx) center visits will take place at screening, months 6, 12 and 18 after initiating IS dose reduction. A protocol driven liver biopsy to adjudicate the endpoint will be performed at 18 months. The duration of the study from time of starting IS dose reduction to the primary endpoint assessment is 18 months. The primary objective is to assess the efficacy of 50 percent IS dose reduction in children with Liver transplants (LTxs)

Liver Transplant

National Institute of Allergy and Infectious Diseases (NIAID)100 participantsStarted May 2026

San Francisco, California, United States • Aurora, Colorado, United States • Washington D.C., District of Columbia, United States +7 more locations

Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

Rheumatoid Arthritis Trials in Other Cities

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Neuroendocrine Tumors

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy

Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury

FOG-001 in Locally Advanced or Metastatic Solid Tumors

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Evaluation of the Efficacy and Safety of LevoCept

Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies

Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants

Study for AZD4360 in Participants With Advanced Solid Tumours

Other Conditions in Chicago